Cargando…
Lung function monitoring in patients with duchenne muscular dystrophy on steroid therapy
BACKGROUND: Duchenne muscular dystrophy (DMD) is a sex-linked inherited muscle disease characterized by a progressive loss in muscle strength and respiratory muscle involvement. After 12 years of age, lung function declines at a rate of 6 % to 10.7 % per year in patients with DMD. Steroid therapy ha...
Autores principales: | Machado, Darlene L, Silva, Elaine C, Resende, Maria B D, Carvalho, Celso R F, Zanoteli, Edmar, Reed, Umbertina C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514262/ https://www.ncbi.nlm.nih.gov/pubmed/22889007 http://dx.doi.org/10.1186/1756-0500-5-435 |
Ejemplares similares
-
Air stacking: effects on pulmonary function in patients
with spinal muscular atrophy and in patients with congenital muscular dystrophy,
por: Marques, Tanyse Bahia Carvalho, et al.
Publicado: (2014) -
Trends in steroid therapy for Duchenne muscular dystrophy in Japan
por: Takeuchi, Fumi, et al.
Publicado: (2016) -
The Duchenne muscular dystrophy gene and cancer
por: Jones, Leanne, et al.
Publicado: (2020) -
Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy
por: ANGELINI, CORRADO, et al.
Publicado: (2012) -
Gene Therapy for Duchenne Muscular Dystrophy
por: Elangkovan, Nertiyan, et al.
Publicado: (2021)